ArticleScientific reports2022

Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab.

Michela Palleschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.